参考文献/References:
[1]Roda G,Chien NG,Kotze PG,et al.Crohn’s disease[J].Nature reviews Disease Primers,2020,6(1):22.[2]郑家驹,史肖华,竺霞霜,等.我国克罗恩病不同年代发病率及患病率的比较[J].中华内科杂志,2011,50(7):597-600.[3]Kuai XY,Yu SY,Cui XF,et al.LncRNA LUCAT1 as a Plasma Biomarker for Assessing Disease Activity in Adult Patients with Crohn’s Disease[J].Gastroenterol Res Pract,2021,2021:5557357.[4]Haberman Y,BenShoshan M,Di Segni A,et al.Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn Disease[J].Inflamm Bowel Dis,2018,24(2):346-360.[5]Wei W,Ji X,Guo X,et al.Regulatory Role of N6 -methyladenosine (m6 A) Methylation in RNA Processing and Human Diseases[J].J Cell Biochem,2017,118(9):2534-2543.[6]Nishizawa Y,Konno M,Asai A,et al.Oncogene c-Myc promotes epitranscriptome m6A reader YTHDF1 expression in colorectal cancer[J].Oncotarget,2017,9(7):7476-7486. [7]Zhu S,Wang JZ,Chen D,et al.An oncopeptide regulates m6A recognition by the m6A reader IGF2BP1 and tumorigenesis[J].Nat Commun,2020,11(1):1685.[8]Oerum S,Meynier V,Catala M,et al.A comprehensive review of m6A/m6Am RNA methyltransferase structures[J].Nucleic Acids Res,2021,49(13):7239-7255.[9]Zhang T,Ding C,Chen H,et al.m6A mRNA modification maintains colonic epithelial cell homeostasis via NF-κB-mediated antiapoptotic pathway[J].Sci Adv,2022,8(12):eabl5723.[10]Sebastian-delaCruz M,Olazagoitia-Garmendia A,Gonzalez-Moro I,et al.Implication of m6A mRNA Methylation in Susceptibility to Inflammatory Bowel Disease[J].Epigenomes,2020,4(3):16.[11]Elamir A,Shaker O,Kamal M,et al.Expression profile of serum LncRNA THRIL and MiR-125b in inflammatory bowel disease[J].PLoS One,2022,17(10):e0275267. [12]Matsumura K,Kawasaki Y,Miyamoto M,et al.The novel G-quadruplex-containing long non-coding RNA GSEC antagonizes DHX36 and modulates colon cancer cell migration[J].Oncogene,2017,36(9):1191-1199.[13]Annunziato F,Cosmi L,Santarlasci V,et al.Phenotypic and functional features of human Th17 cells[J].J Exp Med,2007,204(8):1849-1861.[14]Acosta-Rodriguez EV,Rivino L,Geginat J,et al.Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells[J].Nat Immunol,2007,8(6):639-646.[15]Korn T,Betttlli E,Oukka M,et al.IL-17 and Th17cells[J].Annu Rev Immunol,2009,27:485-517.[16]裴中美,赵振亚,肖静波,等.白细胞介素-17在活动期炎症性肠病患者血浆和肠黏膜中的表达及其意义[J].胃肠病学,2016,21(9):549-553.[17]de Souza HS,Fiocchi C.Immunopathogenesis ofIBD: current state of the art[J].Nat Rev Gastroenterol Hepatol,2016,13(1):13-27.[18]Uhlig HH,Powrie F.Translating immunology intotherapeutic concepts for inflammatory bowel disease[J].Annu Rev Immunol,2018,36:755-781.[19]Zhang C,Liu LW,Sun WJ,et al.Expressions of E-cadherin, p120ctn, β-catenin and NF-κB in ulcerative colitis[J].J Huazhong Univ Sci Technolog Med Sci,2015,35(3):368-373.[20]Han YM,Koh J,Kim JW,et al.NF-kappa B activation correlates with disease phenotype in Crohn’s disease[J].PLoS One,2017,12(7):e0182071.[21]李旺林,刘梦鳌,曹杰,等.TLR4在LPS 诱导的结肠炎症恢复中的作用[J].中国病理生理杂志,2017,33(2):336-343．[22]Lu TX,Zheng Z,Zhang L,et al.A new model of spontaneous colitisin mice induced by deletion of an RNA m(6)A methyltransferasecomponent METTL14 in T cells[J].Cell Mol Gastroenterol Hepatol,2020,10(4):747-761.[23]Wei H,Li Z,Liu F,et al.The Role of FTO in Tumors and Its Research Progress[J].Curr Med Chem,2022,29(5):924-933.[24]Cui J,Wang L,Ren X,et al.LRPPRC:A Multifunctional Protein Involved in Energy Metabolism and Human Disease[J].Front Physiol,2019,10:595.[25]Dragasevic S,Stankovic B,Kotur N,et al.Metabolic syndrome ininflammatory bowel disease: association with genetic markers of obesityand inflammation[J].Metab Syndr Relat Disord,2020,18(1):31-38.[26]Chang JY,Cheon JH.Thiopurine Therapy in Patients With Inflammatory Bowel Disease:A Focus on Metabolism and Pharmacogenetics[J].Dig Dis Sci,2019,64(9):2395-2403.[27]Keller DS,Windsor A,Cohen R,et al.Colorectal cancer in inflammatorybowel disease: review of the evidence[J].Tech Coloproctol,2019,23(1):3-13.[28]Nishio T,Kurabe N,Goto-Inoue N,et al.Immunohistochemical expressionanalysis of leucine-rich PPR-motif-containing protein (LRPPRC), acandidate colorectal cancer biomarker identified by shotgun proteomicsusing iTRAQ[J].Clin Chim Acta,2017,471:276-282.
相似文献/References:
[1]曾 翔,文 星,常一航,等.营养风险筛查和BMI在克罗恩病患者营养评估中的应用[J].医学信息,2019,32(08):133.[doi:10.3969/j.issn.1006-1959.2019.08.039]
ZENG Xiang,WEN Xing,CHANG Yi-hang,et al.Application of Nutritional Risk Screening and BMI in Nutritional Assessment of Patients with Crohn's Disease[J].Journal of Medical Information,2019,32(01):133.[doi:10.3969/j.issn.1006-1959.2019.08.039]
[2]王莹洁,戴迟兵.益生菌在炎症性肠病中的应用研究[J].医学信息,2020,33(22):42.[doi:10.3969/j.issn.1006-1959.2020.22.013]
WANG Ying-jie,DAI Chi-bing.Study on the Application of Probiotics in Inflammatory Bowel Disease[J].Journal of Medical Information,2020,33(01):42.[doi:10.3969/j.issn.1006-1959.2020.22.013]
[3]郑鑫辉,崔慧丽,杨铁毅,等.粪乳铁蛋白、维生素D水平与克罗恩病患者骨质疏松的相关性[J].医学信息,2021,34(05):114.[doi:10.3969/j.issn.1006-1959.2021.05.032]
ZHENG Xin-hui,CUI Hui-li,YANG Tie-yi,et al.Correlation Between Fecal Lactoferrin,Vitamin D Levels and Osteoporosis in Crohn’s Disease[J].Journal of Medical Information,2021,34(01):114.[doi:10.3969/j.issn.1006-1959.2021.05.032]
[4]郑鑫辉,崔慧丽,邵 进,等.克罗恩病患者骨质疏松症的影响因素分析[J].医学信息,2021,34(08):68.[doi:10.3969/j.issn.1006-1959.2021.08.018]
ZHENG Xin-hui,CUI Hui-li,SHAO Jin,et al.Analysis of Influencing Factors of Osteoporosis in Patients with Crohn’s Disease[J].Journal of Medical Information,2021,34(01):68.[doi:10.3969/j.issn.1006-1959.2021.08.018]
[5]马靖琳,王 婷,肖红斌,等.基于公共数据库分析FOXM1在软组织肉瘤中的表达及临床预后意义[J].医学信息,2024,37(01):1.[doi:10.3969/j.issn.1006-1959.2024.01.001]
MA Jing-lin,WANG Ting,XIAO Hong-bin,et al.Expression and Prognostic Significance of FOXM1 Gene in Soft Tissue Sarcomas Based on the Public Database[J].Journal of Medical Information,2024,37(01):1.[doi:10.3969/j.issn.1006-1959.2024.01.001]